Investing Profile

David Morris

Advisor
President, Head of Therapeutics and Technology at Valo Health
Berkeley, California
Photo of David Morris, Advisor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Advisor
1
CompanyStageDateRound SizeTotal Raised
Soteria Biotherapeutics
Series AMay 2021$42M
$42M
Co-investors: Keno Gutierrez (BGV (BioGeneration Ventures)), David Allison (Westlake Village BioPartners)
Operating Partner Novartis Venture Fund2020 - 2021
Managing Director Novartis Venture Fund2018 - 2020